Literature DB >> 2425234

Viral nucleoprotein can be demonstrated on the surface of lymphocytic choriomeningitis virus-infected cells.

W Zeller, M Bruns, F Lehmann-Grube.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425234     DOI: 10.1007/bf02122422

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  6 in total

1.  Studies on the mechanism of lymphocytic choriomeningitis virus homologous interference.

Authors:  M Bruns; W Zeller; F Lehmann-Grube
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

2.  Lymphocytic choriomeningitis virus. V. Proposed structural arrangement of proteins in the virion.

Authors:  M Bruns; F Lehmann-Grube
Journal:  J Gen Virol       Date:  1983-10       Impact factor: 3.891

3.  Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization.

Authors:  M Bruns; J Cihak; G Müller; F Lehmann-Grube
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

4.  Lymphocytic choriomeningitis virus. II. Characterization of extractable complement-fixing activity.

Authors:  H H Geschwender; G Rutter; F Lehmann-Grube
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

5.  Monoclonal antibodies to lymphocytic choriomeningitis and pichinde viruses: generation, characterization, and cross-reactivity with other arenaviruses.

Authors:  M J Buchmeier; H A Lewicki; O Tomori; M B Oldstone
Journal:  Virology       Date:  1981-08       Impact factor: 3.616

6.  Lymphocytic choriomeningitis virus. III. Structural proteins of the virion.

Authors:  M Bruns; L Martínez Peralta; F Lehmann-Grube
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

  6 in total
  1 in total

1.  Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.

Authors:  P Seiler; M A Bründler; C Zimmermann; D Weibel; M Bruns; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-02-16       Impact factor: 14.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.